|
Search
Collections
Benchmarks
Upload document
Indication
HER2-Positive Advanced Biliary Tract Cancer
Rename entity
Add alias
Merge entity
Delete entity
Embed entity
1 clinical trial
1 product
Product
Zanidatamab
Clinical trial
Expanded Access Use of Zanidatamab for the Treatment of HER2-Positive Advanced Solid Tumor
Status: